Biblio

Export 876 results:
Author Title Type [ Year(Desc)]
Filters: Keyword is Humans  [Clear All Filters]
2024
Y. Zhu, Wu, Y., Shi, L., Yang, Y., Wang, Y., Pan, D., He, S., Wang, L., and Li, J., “Association of Plastic Exposure with Cognitive Function Among Chinese Older Adults.”, J Alzheimers Dis, vol. 101, no. 3, pp. 1015-1025, 2024.
S. Ge, Kitamura, T., Zha, L., Komatsu, M., Komukai, S., Murata, F., Maeda, M., Gon, Y., Kimura, Y., Kiyohara, K., Sobue, T., and Fukuda, H., “Association of Statin Use with Dementia Risk Among Older Adults in Japan: A Nested Case-Control Study Using the LIFE Study.”, J Alzheimers Dis, vol. 100, no. 3, pp. 987-998, 2024.
X. - X. Zhang, Wang, H. - R., Hu, Y. - Z., Sun, H. - M., Feng, Y. - X., and Jia, J. - J., “Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies.”, J Alzheimers Dis, vol. 98, no. 2, pp. 373-385, 2024.
Z. Li, Fan, Z., and Zhang, Q., “The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer's Disease: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 98, no. 1, pp. 13-32, 2024.
J. R. M. Coimbra, Resende, R., Custódio, J. B. A., Salvador, J. A. R., and Santos, A. E., “BACE1 Inhibitors for Alzheimer's Disease: Current Challenges and Future Perspectives.”, J Alzheimers Dis, vol. 101, no. s1, pp. S53-S78, 2024.
I. J. Sible and Nation, D. A., “Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1851-1860, 2024.
W. B. Grant, “A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. s1, pp. S165-S178, 2024.
Y. Zeng, Cao, S., Pang, K., Tang, J., and Lin, G., “Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.”, J Alzheimers Dis, vol. 97, no. 1, pp. 229-237, 2024.
P. P. Chum, Bishara, M. A., Solis, S. R., and Behringer, E. J., “Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.”, J Alzheimers Dis, vol. 99, no. s2, pp. S187-S234, 2024.
J. Wang, Zhang, G., Lai, H., Li, Z., Shen, M., Li, C., Kwan, P., O'Brien, T. J., Wu, T., Yang, S., Zhang, X., and Zhang, L., “Characterizing Gut Microbiota in Older Chinese Adults with Cognitive Impairment: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 761-771, 2024.
C. L. Satizabal, Himali, J. Jung, Conner, S. C., Beiser, A. S., Maillard, P., Vasan, R. S., DeCarli, C., and Seshadri, S., “Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community.”, J Alzheimers Dis, vol. 102, no. 2, pp. 449-458, 2024.
C. Rosario Ilardi, Menichelli, A., Michelutti, M., Cattaruzza, T., Federico, G., Salvatore, M., Iavarone, A., and Manganotti, P., “On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 101, no. 1, pp. 293-308, 2024.
L. Fernández-Romero, Morello-García, F., Laforce, R., Delgado-Alonso, C., Delgado-Álvarez, A., Gil-Moreno, M. José, Lavoie, M., Matías-Guiu, J., Cuetos, F., and Matías-Guiu, J. A., “Comparative accuracy of Mini-Linguistic State Examination, Addenbrooke's Cognitive Examination, and Depistage Cognitif de Quebec for the diagnosis of primary progressive aphasia.”, J Alzheimers Dis, vol. 102, no. 1, pp. 67-76, 2024.
I. Terao and Kodama, W., “Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease”, J Alzheimers Dis, vol. 98, no. 3, pp. 825-835, 2024.
N. Puentes-Díaz, Chaparro, D., Reyes-Marquez, V., Morales-Morales, D., Flores-Gaspar, A., and Alí-Torres, J., “Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S383-S396, 2024.
A. Mahzarnia, Lutz, M. W., and Badea, A., “A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.”, J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
N. Vaishnav, Gonzalez, R., Karunungan, K., Tyler, A., Zheng, W., and Arias, J. J., “Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 1, pp. 187-195, 2024.
V. Michelle M. Anlacan, Lanuza, P. Danielle T., Sanchez, A. Anjelica R., and Jamora, R. Dominic G., “Current Status and Challenges in Dementia Care in the Philippines: A Scoping Review.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1533-1543, 2024.
W. Dombrowski, Mims, A., Kremer, I., Desandes, P. Cano, Rodrigo-Herrero, S., Epps, F., Snow, T., Gutierrez, M., Nasta, A., Epperly, M. Bunce, Manaloto, K., and Hansen, J. Chin, “Dementia Ideal Care: Ecosystem Map of Best Practices and Care Pathways Enhanced by Technology and Community.”, J Alzheimers Dis, vol. 100, no. 1, pp. 87-117, 2024.
C. E. Finch and Burstein, S. M., “Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1581-1588, 2024.
M. S. Weinberg, He, Y., Kivisäkk, P., Arnold, S. E., and Das, S., “Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S355-S365, 2024.
T. Chatzikostopoulos, Gialaouzidis, M., Koutoupa, A., and Tsolaki, M., “The Effects of Pomegranate Seed Oil on Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1961-1970, 2024.
H. Shimada, Doi, T., Tsutsumimoto, K., Makino, K., Harada, K., Tomida, K., and Arai, H., “Elevated Risk of Dementia Diagnosis in Older Adults with Low Frequencies and Durations of Social Conversation.”, J Alzheimers Dis, vol. 98, no. 2, pp. 659-669, 2024.
X. Liang, Wang, Y., Li, S., Fan, J., Zhou, F., Li, X., Li, S., and Li, Y., “Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in Alzheimer's Disease Models.”, J Alzheimers Dis, vol. 100, no. 1, pp. 279-296, 2024.
S. Hermes, Cady, J., Armentrout, S., O'Connor, J., Holdaway, S. Carlson, Cruchaga, C., Wingo, T., and Greytak, E. McRae, “Epistatic Features and Machine Learning Improve Alzheimer's Disease Risk Prediction Over Polygenic Risk Scores.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1425-1440, 2024.

Pages